Boutoille, D.
Publications
P299
J. Antimicrob. Chemother. 2025, 80, 472-477.
Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home-acquired urinary tract infections.
P265
JAC Antimicrob. Resist. 2023, 5.
Expert consensus on monitoring antimicrobial stewardship in French nursing homes using assessed reimbursement database indicators.
P264
Antimicrob. Resist. Infect. Control. 2023, 12:41.
Qualitative assessment of the national initiative to implement antimicrobial stewardship centres in French administrative regions.
P262
J. Antimicrob. Chemother. 2023, 78, 965-974.
Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.
P224
Med. Mal. Infect. 2020, 50, 742-745.
Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis.
doi: 10.1016/j.medmal.2020.07.005
P191
La Lettre de l'Infectiologue • Tome XXXIV - n° 3 - mai-juin 2019.
Brain abscess to Rasamsonia argillacea in a patient with chronic granulomatous disease.
P81
Med. Mal. Infect., 2009,
Contribution de la biologie moléculaire et de l'antigénémie galactomannane aspergillaire au diagnostic de l'histoplasmose.
doi:10.1016/j.medmal.2009.10.005, sous presse.
Autres publications scientifiques
PS28
J Antimicrob Chemother 2023, 78(12):2919-2925.
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
PS24
J Antimicrob Chemother 2023, 8, 965-974.
Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.
PS13
Front. Public Health 2023, 11, 1136980.
Social representations of mask wearing in the general population during the COVID-19 pandemic.
PS08
J. Infect. Dis. 2022, 225, 868-880.
PRONOCYSTIS Study Group. Epidemiology and clinical impact of respiratory cinfections at diagnosis of Pneumocystis jirovecii pneumonia.